| 0054-0434 | DIPYRIDAMOLE Tablets USP | Carilion Materials Management |
| 00597-001 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Rebel Distributors Corp. |
| 0074-2043 | Dipyridamole Injection For Intravenous Injection R x only | HOSPIRA, INC. |
| 0074-2043-10 | Dipyridamole Injection For Intravenous Injection R x only | HOSPIRA, INC. |
| 0115-1070 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0115-1070-01 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0115-1071 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0115-1071-01 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0115-1072 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0115-1072-01 | Dipyridamole Tablets, USP (25 mg, 50 mg and 75 mg) Rx only | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals Private Limited |
| 0404-9852 | Dipyridamole 5 mg/mL Injection, USP 10 mL Single Dose Vial | Henry Schein, Inc. |
| 0404-9852-10 | Dipyridamole 5 mg/mL Injection, USP 10 mL Single Dose Vial | Henry Schein, Inc. |
| 0409-2043 | Dipyridamole Injection For Intravenous Injection R x only | HOSPIRA, INC. |
| 0409-2043-02 | Dipyridamole Injection For Intravenous Injection R x only | HOSPIRA, INC. |
| 0597-0001 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Physicians Total Care, Inc. |
| 0597-0001 | These highlights do not include all the information needed to use AGGRENOX safely and effectively. See full prescribing information for AGGRENOX. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Carilion Materials Management |
| 0641-2569 | Dipyridamole Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0641-2569 | Dipyridamole 5 mg/mL Injection, USP 10 mL Single Dose Vial | Henry Schein, Inc. |
| 0641-2569 | DIPYRIDAMOLE INJECTION, USP 50mg/10mL (5mg/mL) 10mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 0641-2569-41 | Dipyridamole Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0641-2569-44 | Dipyridamole Injection, USP Rx only | Hikma Pharmaceuticals USA Inc. |
| 0904-7056 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Major Pharmaceuticals |
| 0904-7056-99 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Major Pharmaceuticals |
| 16714-964 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | NorthStar Rx LLC | Dr. Reddy's Laboratories Limited-FTO III |
| 16714-964-01 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | NorthStar Rx LLC | Dr. Reddy's Laboratories Limited-FTO III |
| 21695-656 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Rebel Distributors Corp. |
| 21695-656-60 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Rebel Distributors Corp. |
| 42291-116 | Aspirin and Extended-release Dipyridamole Capsules These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | AvKARE |
| 42291-116-60 | Aspirin and Extended-release Dipyridamole Capsules These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | AvKARE |
| 42571-274 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Micro Labs Limited |
| 42571-274 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Bryant Ranch Prepack |
| 42571-274-60 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Micro Labs Limited |
| 43598-339 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Dr. Reddy's Laboratories Inc | Dr. Reddy's Laboratories Limited-FTO III |
| 43598-339-60 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Dr. Reddy's Laboratories Inc | Dr. Reddy's Laboratories Limited-FTO III |
| 47335-927 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use only Initial U.S. Approval: 1999 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-927-83 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use only Initial U.S. Approval: 1999 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 47335-927-86 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use only Initial U.S. Approval: 1999 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited |
| 49884-007 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Major Pharmaceuticals |
| 49884-007 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Endo USA, Inc. |
| 49884-007 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Par Health USA, LLC |
| 49884-007-02 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Endo USA, Inc. |
| 49884-007-02 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES . ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Par Health USA, LLC |
| 51662-1447 | DIPYRIDAMOLE INJECTION, USP 50mg/10mL (5mg/mL) 10mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 51662-1447-1 | DIPYRIDAMOLE INJECTION, USP 50mg/10mL (5mg/mL) 10mL VIAL | HF Acquisition Co LLC, DBA HealthFirst |
| 51808-204 | DIPYRIDAMOLE | AnazaoHealth Corporation |
| 51808-204-01 | DIPYRIDAMOLE | AnazaoHealth Corporation |
| 54868-5143 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Physicians Total Care, Inc. |
| 54868-5143-0 | These highlights do not include all the information needed to use Aggrenox Capsules safely and effectively. See full prescribing information for Aggrenox Capsules. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Physicians Total Care, Inc. |
| 63629-5045 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Bryant Ranch Prepack |
| 63629-5045-1 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Bryant Ranch Prepack |
| 65162-596 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC |
| 65162-596-06 | These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC |
| 65841-662 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-662-01 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-662-05 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-662-10 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-662-77 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-663 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-663-01 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-663-05 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-663-10 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-663-77 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-664 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-664-01 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-664-05 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-664-10 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 65841-664-77 | Dipyridamole Tablets, USP | Zydus Lifesciences Limited |
| 68151-2996 | DIPYRIDAMOLE Tablets USP | Carilion Materials Management |
| 68151-2996-0 | DIPYRIDAMOLE Tablets USP | Carilion Materials Management |
| 68151-3971 | These highlights do not include all the information needed to use AGGRENOX safely and effectively. See full prescribing information for AGGRENOX. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Carilion Materials Management |
| 68151-3971-6 | These highlights do not include all the information needed to use AGGRENOX safely and effectively. See full prescribing information for AGGRENOX. AGGRENOX® (aspirin/extended-release dipyridamole) Capsules Initial U.S. Approval: 1999 | Carilion Materials Management |
| 68382-187 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-187-01 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-187-05 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-187-10 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-187-77 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-188 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-188 | Dipyridamole Tablets, USP | REMEDYREPACK INC. |
| 68382-188-01 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-188-05 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-188-10 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-188-77 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-189 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-189-01 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-189-05 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-189-10 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68382-189-77 | Dipyridamole Tablets, USP | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited |
| 68462-405 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-405-30 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 68462-405-60 | These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral use Initial U.S. Approval: 1999 | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited |
| 69584-181 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 69584-181-10 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 69584-182 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 69584-182-10 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 69584-183 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 69584-183-10 | DIPYRIDAMOLE TABLETS, USP 25 mg, 50 mg, and 75 mg | Oxford Pharmaceuticals, LLC |
| 70518-4650 | Dipyridamole Tablets, USP | REMEDYREPACK INC. |
| 70518-4650-0 | Dipyridamole Tablets, USP | REMEDYREPACK INC. |
| 70518-4650-1 | Dipyridamole Tablets, USP | REMEDYREPACK INC. |